@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CQ2KMNMH-W skos:prefLabel "Piperidines"@en, "Pipéridines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-XB11XXSH-P . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XB11XXSH-P skos:hiddenLabel "Novo-Domperidone"@en, "Domperidon AL"@en, "Nauzelin"@en, "R-33,812"@fr, "R-33,812"@en, "Domperidon Hexal"@en, "Domperidon Stada"@en, "Domperidone Maleate"@en, "Domidon"@en, "R33812"@fr, "PMS-Domperidone"@en, "Péridys"@en, "Domperidon-TEVA"@en, "Nu-Domperidone"@en, "Domperidone Monohydrochloride"@en, "Domperidone Maleate (1:1)"@en, "Gastrocure"@en, "R-33812"@en, "R-33812"@fr, "Motilium"@en, "Maléate de dompéridone"@fr, "Domperidona Gamir"@en, "Monochlorhydrate de dompéridone"@fr, "Ratio-Domperidone"@en, "Apo-Domperidone"@en ; mesh:allowableQualifier jvr:-R3QWLHRG-V, jvr:-Q3979798-W, jvr:-NB0XHT3S-N, jvr:-NFTHND7Q-8, jvr:-D0F21513-5, jvr:-H7K65Q8S-Z, jvr:-G30ZJ446-J, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9, jvr:-SBNWSM1T-R, jvr:-L6C0XPHT-4, jvr:-BT300B3G-Q, jvr:-WK5F724J-1, jvr:-M63HSDM7-1, jvr:-HQRFT0C6-B, jvr:-T9HQD7ST-J, jvr:-W6SQV79N-S, jvr:-G4R176S9-J, jvr:-XV06LPML-W, jvr:-TJHVZCRZ-0, jvr:-S0CS1X5R-5, jvr:-CB30NGKB-3, jvr:-THHNVC7V-3, jvr:-NKM836P1-M, jvr:-R0ZCQ8X6-J ; skos:altLabel "2H-Benzimidazol-2-one, 5-chloro-1-(1-(3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-"@fr, "2H-Benzimidazol-2-one, 5-chloro-1-(1-(3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-"@en, "Domperidon"@en, "5587267Z69"@en, "5587267Z69"@fr, "83898-65-1 (maleate (1:1))"@fr, "83898-65-1 (maleate (1:1))"@en, "899U5WF46A"@fr, "899U5WF46A"@en, "62781-53-7 (mono-HCl)"@fr, "62781-53-7 (mono-HCl)"@en, "99497-03-7 (maleate)"@fr, "99497-03-7 (maleate)"@en, "57808-66-9 (Domperidone)"@fr, "57808-66-9 (Domperidone)"@en ; owl:sameAs ; dc:modified "2017-05-24"^^xsd:date ; skos:broader jvr:-CQ2KMNMH-W, jvr:-RM6WX5H5-Q ; mesh:pharmacologicalAction jvr:-X1H75KMP-P, jvr:-BN87VH98-Z ; skos:inScheme jvr: ; dc:created "1981-05-13"^^xsd:date ; a skos:Concept, mesh:Descriptor ; skos:prefLabel "Dompéridone"@fr, "Domperidone"@en ; skos:definition "A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms."@en ; dc:established "1982-01-01"^^xsd:date . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-RM6WX5H5-Q skos:prefLabel "Benzimidazoles"@fr, "Benzimidazoles"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-XB11XXSH-P . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-BN87VH98-Z skos:prefLabel "Antagonistes de la dopamine"@fr, "Dopamine Antagonists"@en ; a mesh:Descriptor, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-X1H75KMP-P skos:prefLabel "Antiemetics"@en, "Antiémétiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .